BCL2A1 and depressive symptom measurement: Dysregulation and/or dysfunction of corticosteroid receptors (i.e., mineralocorticoids (MRs) and GRs in the hippocampus and basolateral amygdala [36,37,38,39,40], GRs in the periventricular nucleus, may be involved in the development of depression and anxiety disorders [39].